International Clinical Advisory Board Appointment

RNS Number : 6931Q
Surgical Innovations Group PLC
17 October 2013



Surgical Innovations Group plc

("SI" or the "Group")


International Clinical Advisory Board Appointment


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Austrian staff surgeon Bernhard Dauser to its International Clinical Advisory Board ('ICAB') with immediate effect.


Bernhard Dauser, MD, is a staff surgeon specialising in advanced laparoscopic procedures, flexible endoscopy and the development of novel instruments and techniques. He graduated from the University of Vienna in 2003 and currently works as a staff surgeon at St John of God Hospital in Vienna.


The ICAB complements the well established UK CAB and provides a means for SI to engage with surgeons at the forefront of innovation. Bernhard is an experienced surgeon and has been introduced to ICAB following close collaboration with SI's Austrian/ German distributor.


Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "SI is thrilled to welcome Bernhard to the ICAB. We now have three ICAB members to ensure that SI receives up to date feedback and advice on the continually developing MIS products and the understanding of the market SI works in."






Surgical Innovations Group plc

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer





Panmure Gordon (Nominated Advisor & Broker)

Tel: +44 (0) 20 7886 2500

Fred Walsh / Freddy Crossley (Corporate Finance)


Adam Pollock/ Victoria Boxall (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303




Notes to Editors:


About Surgical Innovations Group plc -


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings